Research and Clinical Trials

Title  
Genentech ML39237: A Phase II Single-Arm Study of Atezolizumab Monotherapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Clinical Evaluation of Novel Blood-Based Diagnostics
Brief Description  
To evaluate the clinical efficacy of atezolizumab
Who may be Eligible  
Please contact us for eligibility criteria.
Speciality/Disorder  
Lung
Status  
OPEN
Start Date  
06/09/2017
IRB Number  
00021016
Principal Investigator  
Kim, Edward Sanghyun
Contact Name  
Nathan Thompson

For More Information, Contact  Nathan  , Thompson
Phone:  980-487-3241 Fax:    
Email:  Nathan.Thompson@carolinashealthcare.org
Address:201 East Grover Street Shelby, 28150
Close